We are live on ! Find out more
LEXX icon

Lexaria Bioscience

27 hedge funds and large institutions have $3.25M invested in Lexaria Bioscience in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

4% less funds holding

Funds holding: 28 → 27 (-1)

7.62% less ownership

Funds ownership: 14.37% → 6.75% (-7.6%)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

90% less capital inflows, than outflows

Capital inflows: $318K | Capital outflows: $3.05M

Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

LEXX Hedge Fund Activity: Q3 2024 in Review

27 of the 6,991 institutional investors tracked by Wall St. Rank reported a position in Lexaria Bioscience (LEXX) for Q3 2024, worth a combined $3.25M — down 43% from $5.72M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of LEXX and 6 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.

The largest buyer was Geode Capital Management, adding an estimated $113K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.84M sold.

  • 27 institutional investors held Lexaria Bioscience (LEXX) as of Q3 2024, down from 28 in Q2 2024.
  • Funds reported $3.25M of Lexaria Bioscience stock for Q3 2024, down 43% quarter-over-quarter.
  • 6 funds opened new Lexaria Bioscience positions in Q3 2024 and 7 closed out, a net change of -1 holder.
  • The largest Lexaria Bioscience buyer in Q3 2024 was Geode Capital Management, an estimated $113K added.
  • The largest Lexaria Bioscience seller in Q3 2024 was Armistice Capital, an estimated $2.84M sold.

Based on aggregated 13F filings for Q3 2024.